Chief Investigator: Dr Veronika Bandara

Funding Amount : $100,000

Recipient: The University of Adelaide

Overview: Neuroblastoma is a deadly paediatric cancer. We will test a new personalised immunotherapy, made by modifying the patient’s own immune cells, as a treatment for neuroblastoma. Preliminary studies showed high cytotoxicity against neuroblastoma cell lines, and now further studies are needed to prove the safety and efficacy of this immunotherapy.